UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/275/0.01/18.09.24 Stock

Warrant

1722T

DE000HC98XW6

Market Closed - Euronext Paris 12:30:02 2024-05-08 EDT
0.04 EUR -20.00% Intraday chart for UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/275/0.01/18.09.24
Current month-20.00%
1 month-84.62%

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
1722T
ISINDE000HC98XW6
Date issued 2023-09-14
Strike 275
Maturity 2024-09-18 (122 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.41
Lowest since issue 0.04
Delta0.2x
Omega 7.249
Premium37.23x
Gearing37.16x
Moneyness 0.7433
Difference Strike 78.2
Difference Strike %+28.44%
Spread 0.03
Spread %42.86%
Theoretical value 0.0550
Implied Volatility 46.81 %
Total Loss Probability 87.33 %
Intrinsic value 0.000000
Present value 0.0550
Break even 280.50 €
Theta-0x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
196.8 EUR
Average target price
250.1 EUR
Spread / Average Target
+27.07%
Consensus
  1. Stock Market
  2. Warrants
  3. 1722T Warrant
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW